California law student's death linked to weight loss drug

Student, 19, died of a cardiac arrhythmia.

New research suggests GLP-1 weight-loss drugs are changing what Scottish consumers buy, with spending shifting away from snacks and processed foods towards healthier options.

Research from The Knowledge Bank, part of the Scotland Food & Drink Partnership, points to a shift in purchasing trends across the country.

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients  WSJ

Josephine Nasr, 19, died of a cardiac arrhythmia in her room at the University of East London in September 2025, an East London Coroner's Court heard last week.

Health fear over growing misuse of weight-loss drugs in elite sport  The Times

Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.

Amazon joins the federal Medicare GLP-1 Bridge Program, automating prior authorization and offering same-day delivery in more than 3,100 cities

GLP-1 drugs for weight loss are on the rise, with 11 percent of Americans saying they take one in a recent poll

Amazon Pharmacy said Thursday it has become one of the latest major providers offering the medication under a Medicare program.

Gracie McGraw reveals how Ozempic brought back her eating disorder after being prescribed the weight loss drug for her PCOS diagnosis in 2022.

The NHS GP is urging people to avoid the product after he received messages about it from followers and family members

Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.

International research suggests losing weight may help people get a job - and their New Zealand counterparts say it can't be ruled out here, either.

Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet

Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.